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Pathogen eradication requires synergy be-
tween the innate and adaptive immune re-
sponse. DCs are crucial in this respect because 
they effi     ciently capture and process antigens 
and deliver them to T cells, (1, 2). In addi-
tion, DCs direct immune responses by cell-
to-cell contact and cytokine secretion (3, 4). 
IL-12 is a heterodimeric cytokine that plays 
a key role in the induction of cell-mediated 
immunity to pathogens (4). This cytokine is 
produced by macrophages and CD8+ DCs 
upon Toll-like receptor (TLR) ligation (5–7), 
and in turn, it induces IFN-γ production and 
Th1 diff  erentiation (8). Thus, IL-12 is an impor-
tant bridge between the innate and adaptive im-
mune systems.
However, Th1 responses can also take place 
in the absence of IL-12 (4, 9–11). Consistent 
with this fi  nding, IL-12 defi  ciency leads to a 
much less severe phenotype than IFN-γ defi  -
ciency (12, 13). Other pathways that have been 
implicated in directing Th1 diff  erentiation in-
clude direct cell–cell signaling through Notch 
(14–16). The interactions between Notch re-
ceptor and its ligands represent an evolutionary 
conserved pathway important for cell fate deci-
sions (17). Mammals express four Notch genes 
(Notch 1–4) and fi  ve ligands for Notch from two 
conserved families, Jagged (Jagged 1 and 2) and 
Delta (Delta 1, 3, and 4; references 18 and 19). 
Notch signaling involves regulated proteolysis 
and nuclear translocation of the cytoplasmic 
domain of Notch, which functions as a tran-
scription factor (17–19). The role of Notch in 
regulating lineage decisions in hematopoiesis 
and in the developing thymus has been well 
documented (18). However, the role of Notch 
signaling in mature T cell activation and Th 
polarization remains controversial (15, 16, 20–
22). There is evidence that Notch activation 
is required to promote Th2 diff  erentiation in 
vivo (21) and that Delta-like Notch ligands 
might promote Th1 polarization in vitro and in 
vivo (14, 16). Furthermore, inhibitors of γ-secre-
tase, an enzyme regulating signaling through 
all four Notch receptors, block Th1 polariza-
tion in vivo and in vitro (15). In contrast, ab-
lation of Notch 1 or RBP-Jk/CSL, which is 
a mediator of Notch function, had no detect-
able eff  ect on Th1 polarization in vitro and in 
vivo (20, 21).
Here, we report that although LPS specifi  -
cally induces MyD88-dependent expression of 
IL-12 by CD8+ DCs, it also induces Delta 4 
on spleen CD8− DCs, and that the latter leads 
to IL-12–independent Th1 diff  erentiation in 
vivo. Thus, IL-12 and Notch mediate redundant 
MyD88-dependent pathways to Th1 diff  eren-
tiation in the two major spleen DC subsets, and 
this redundancy is at least in part responsible for 
the reported discrepancies in the role of Notch 
in Th1 development.
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Toll-like receptor (TLR) ligation is believed to skew T cell responses toward T helper (Th)1 
differentiation by inducing interleukin (IL)-12 secretion by CD8+ dendritic cells (DCs). 
However, TLR-dependent Th1 responses occur in the absence of IL-12. To determine how 
DCs induce Th1 differentiation in the absence of IL-12, we examined the response of 
IL-12–defi  cient DCs to bacterial lipopolysaccharide (LPS). We fi  nd that LPS activates MyD88-
dependent Delta 4 Notch-like ligand expression by CD8− DCs, and that these cells direct 
Th1 differentiation by an IL-12–independent and Notch-dependent mechanism in vitro and 
in vivo. Thus, activation of the two DC subsets by TLR4 leads to Th1 responses by two 
distinct MyD88-dependent pathways.
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RESULTS AND DISCUSSION
DC subsets direct Th1 development in vitro
Among cytokines, IL-4 and IL-12 are factors directing Th2 
and Th1 cell development, respectively (4, 23). Antigen 
presentation by DCs to OVA-specifi  c  TCR  transgenic 
CD4+ T cells (OTII) induces Th1 diff  erentiation in vitro, 
as determined by IFN-γ but not IL-4 secretion, and this 
is enhanced by DC stimulation with LPS (Fig. 1, A–C, 
and Figs. S1 and S2 A, which are available at http://www
.jem.org/cgi/content/full/jem.20062305/DC1; references 
6 and 7). To determine how DC subsets contribute to Th1 
T cell diff  erentiation, we performed antigen presentation 
experiments using CD8+ and CD8− DCs purifi  ed from the 
spleens of mice injected with LPS and controls. We found 
that unstimulated CD8+ DCs induce an increase in IFN-γ 
production, but CD8− DCs were much less active in this 
respect (Fig. 1 D). IL-4 and IL-10 were not detected in 
these same supernatants, suggesting that polarization was 
primarily to Th1. LPS increased IFN-γ production in T cell 
cultures containing CD8+ DCs, but to a much greater extent 
in   cultures containing CD8− DCs, as measured by ELISA 
and ELISPOT (Fig. 1 D and Fig. S2 B). Thus, steady-state 
CD8+ DCs promote Th1 diff  erentiation, but TLR ligation 
enables both DC subsets to skew T cell diff  erentiation in this 
direction (24).
Splenic DC responses to LPS
IL-12 is produced by activated CD8+ DCs after TLR liga-
tion (5–7), and it skews immune responses by inducing pro-
duction of IFN-γ and TNF-α by NK cells and by promoting 
diff  erentiation of Th1 T cells (5, 23, 25). To determine how 
TLR ligation enhances the ability of DCs to induce Th1 dif-
ferentiation, we assayed IL-12 production by DCs purifi  ed 
from wild-type and MyD88-defi  cient mice. Like others, we 
found that LPS injection or LPS addition to cultures of puri-
fi   ed DCs stimulated CD8+ DCs to produce IL-12 in an 
MyD88-dependent manner but failed to induce production 
of this cytokine by CD8− DCs, and neither DC subset pro-
duced IL-4 or IL-10 (Fig. 2, A and B, and not depicted; 
references 6, 7, and 24). Therefore IL-12 secretion cannot 
account for the Th1 responses induced by LPS-activated 
CD8− DCs. IL-12 is not essential for Th1 immune responses 
(9–11). Other cytokines might direct the residual Th1 response 
in IL-12–defi  cient mice, for example IL-18, which pro-
motes IFN-γ production in CD4+ T cells. However, studies 
with Toxoplasma gondii (26) and mycobacteria (27) failed to 
reveal a function for this cytokine in Th1 development in 
the absence of endogenous IL-12. IL-23 is another candidate 
cytokine mediator of Th1 development, but this IL-12–related 
factor shares the p40 subunit, which is defective in IL-12–
mutant mice (9). Therefore, neither IL-18 nor IL-23 can ac-
count for the residual Th1 response found in the absence 
of IL-12.
Delta 1 expression on fi  broblasts can promote Th1 dif-
ferentiation of transgenic CD4 T cells in vitro (14). All 
four Notch receptors are expressed on mature T cells (18). 
Less is known about the expression of Notch ligands on 
DCs. Cultured bone marrow DCs up-regulate Delta 4 
upon LPS stimulation, low levels of Delta 1 have been repor-
ted on spleen DCs, and both Jagged 1 and 2 are expressed 
Figure 1.  LPS increases the capacity of splenic DC subsets to 
  induce Th1 differentiation. (A and B) FACS plots show intracellular IFN-γ 
and IL-4 production by CD4+ OTII T cells cultured with antigen and 
CD11c+ cells (2 × 104/well) purifi  ed from C57BL/6 mice injected with 
25 μg LPS for 12 h. (C) Bar graph indicates IFN-γ production measured by 
ELISA in the supernatant of cultures containing CD4+ OTII T cells, antigen, 
and splenic CD11c+ cells that had been pretreated with 50 ng/ml LPS for 
6 h in vitro (D) as in B, except that CD8+ or CD8− DCs were used as APCs.JEM VOL. 204, July 9, 2007  1527
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constitutively on bone marrow and spleen DCs (14, 28). To 
determine whether spleen DCs up-regulate Notch ligands 
upon LPS stimulation, we purifi  ed CD8+ and CD8− DCs 
from mice injected with LPS and measured Delta 4 mRNA 
and protein expression by conventional and quantitative 
PCR, as well as by immunoblotting (Fig. 2 C). Although 
Delta 4 was not expressed by DCs in the steady state, it was 
rapidly induced on CD8− but not on CD8+ DCs by LPS, 
and this eff  ect was MyD88 dependent (Fig. 2 D). IL-12 
and Delta 4 synthesis were cell autonomous because iso-
lated CD8+ and CD8− DCs stimulated with LPS in vitro 
expressed these molecules, respectively (Fig. 2, B and E). 
In contrast, Delta 1 and 3 and Jagged 1 and 2 (14) were not 
up-regulated upon LPS stimulation (Fig. 2 F). Thus, LPS 
induces MyD88-dependent IL-12 secretion by CD8+ DCs 
and Delta 4 up-regulation by CD8− DCs, suggesting that 
Delta 4 expression by these cells might be the alternative sig-
nal for Th1 diff  erentiation.
CD8+ and CD8− DCs induce Th1 development 
by different mechanisms
Signaling by direct cell-to-cell contact can also instruct T cell 
diff  erentiation in the thymus and in the periphery. Notch 
family members are important mediators of this type of signal-
ing and contribute to essential aspects of thymocyte develop-
ment and T cell lineage commitment (18, 19). Delta 1 has 
been implicated in directing Th1 development in vitro and in 
vivo, and Jagged is believed to induce Th2 diff  erentiation, but 
the relative roles of IL-12 and the Notch pathway in Th1 dif-
ferentiation in vivo have not been defi  ned (14, 16). To deter-
mine the relative function of IL-12 and Delta 4 in DC-induced 
Th1 differentiation, we purified DCs from LPS-injected 
MyD88−/−, IL12p40−/−, IL-12p35−/−, and wild-type con-
trol mice, cultured them with antigen and naive CD4 T cells, 
and measured IFN-γ production by ELISA and ELISPOT. 
As expected, induction of IFN-γ secretion by CD8+ DCs was 
IL-12 dependent (Fig. 3 A and Fig. S3A, which is available 
Figure 2.  DC subset responses to LPS stimulation. (A) IL-12 secretion 
by CD8+ and CD8− DCs purifi  ed from LPS-injected MyD88−/− or C57BL/6 
mice uninjected controls. Supernatants were harvested after 10 or 
48 h (the 48-h time point is shown), and IL-12p40 was measured by 
ELISA. IL-4 and IL-10 levels were below the limits of detection of the assay 
(5–10 pg/ml). (B) IL-12 secretion by CD8+ and CD8− DCs purifi  ed from 
C57BL/6 mice stimulated with 50 ng/ml LPS for 6–10 h in vitro. (C) RT-PCR 
and quantitative PCR for Delta 4 expression by CD8+ and CD8− DCs 
purifi  ed from LPS-injected C57BL/6 mice and uninjected controls. (Right) 
Western blot for Delta 4 using 4 × 105 cells per lane of lysates from CD8+ 
and CD8− DCs purified from LPS-injected (12 h) C57BL/6 mice and 
controls. The blot was reprobed for α-tubulin. (D) RT-PCR and quantitative 
PCR for Delta 4 expression by CD8− DCs purifi  ed from LPS-injected 
MyD88−/− or C57BL/6 mice and uninjected controls. (E) RT-PCR and 
quantitative PCR for Delta 4 expression by CD8+ and CD8− DCs treated 
for 6 h with 50 ng/ml LPS and untreated controls. (F) Quantitative PCR 
for Delta 1 and 3 and Jagged 1 and 2 expression by CD8− DCs purifi  ed 
from LPS-injected C57BL/6 mice and uninjected controls. GAPDH 
and β-actin controls were used in RT-PCR and quantitative PCR 
experiments, respectively.1528  DC SUBSETS, NOTCH, AND TH POLARIZATION | Skokos and Nussenzweig 
at http://www.jem.org/cgi/content/full/jem.20062305/DC1; 
references 6, 7, and 25). In contrast, induction of Th1 diff  er-
entiation by CD8− DCs was MyD88 dependent but IL-12 
independent (Fig. 3 A). To determine whether Delta 4 signaling 
was required for induction of Th1 diff  erentiation, we blocked it 
using a soluble Delta 4–mFc fusion protein (sD4-mFc; Fig. 3 B 
and Figs. S3 B and S4). As Notch receptor signaling requires 
receptor cross-linking, a mutation was inserted into the Fc 
portion of the Delta 4–Fc fusion protein, thus disabling its ability 
to bind to Fc receptors (Delta 4–mFc). The presence of this 
mutant Delta 4–Fc protein was expected to compete with endo-
genous Delta 4 for binding to Notch, preventing the normal 
function of this molecule expressed on cultured cells. We found 
that the addition of sD4-mFc to cultures of activated CD8− DCs 
did not eff  ect T cell proliferation or antigen-dependent T cell 
activation, as measured by up-regulation of CD69 expression 
(Fig. S5); however, it inhibited induction of IFN-γ secretion 
(Fig. 3 B and Fig. S3 B). In contrast, the addition of sD4-mFc 
to cultures of T cells responding to antigen presented by acti-
vated CD8+ DCs did not have any eff  ect on IFN-γ production 
(Fig. 3 B). We conclude that LPS specifi  cally induces MyD88-
dependent Delta 4 expression by CD8− DCs, and that engage-
ment of this Notch ligand by antigen-responsive T cells directs 
Th1 T cell diff  erentiation.
To further confi  rm the role of Delta 4 in Th1 diff  erentia-
tion, we used I-Ek– and Delta 4 ligand–expressing fi  broblasts 
as APCs to diff  erentiate naive AND TCR transgenic CD4 
T cells (14). We found that surface Delta 4 expression on 
APCs (Fig. S6, available at http://www.jem.org/cgi/content/
full/jem.20062305/DC1) enhanced Th1 development, as 
measured by the induction of IFN-γ but not IL-4 production 
(Fig. 3, C and D). Thus, Delta 4 ligand actively participates 
in Th1 diff  erentiation.
IL-12–independent Th1 responses by Delta 4 Notch-like 
ligand in vivo
Several studies have examined the role of Notch signaling in 
Th polarization, but the results were confl  icting (15, 16, 
20–22). Although some have found that the Notch pathway 
can induce IFN-γ production (14–16), others have shown 
that ablation of Notch 1 or RBP-Jk/CSL, the major media-
tor of signaling through all four Notch receptors, did not 
measurably interfere with Th1 responses (14, 20, 21). How-
ever, the gene knockout experiments were performed using 
IL-12–suffi   cient mice.
To examine the role of Delta 4 in IL-12–independent 
Th1 T cell diff  erentiation in vivo, we asked whether sD4-
mFc could block the diff  erentiation of OVA-specifi  c CD4+ 
T cells into Th1 cells in IL-12p40−/− mice. OTII T cells 
were transferred into IL-12p40−/− or control mice that were 
injected with a mixture of LPS and OVA in the presence 
or absence of sD4-mFc. CD4 T cell clonal expansion and 
Figure 3.  IL-12–independent Th1 differentiation in vitro. (A) IFN-γ 
secretion was measured by ELISA in cultures containing CD4+ OTII T cells, 
antigen, and CD8+ DCs (fi  lled bars) or CD8− DCs (open bars) purifi  ed from 
LPS-injected MyD88−/−, IL-12p40−/−, IL-p35−/−, or C57BL/6 wild-type 
mice. Anti–IL-12p40/p70 indicates cultures to which anti–IL-12 was 
added. (B) IFN-γ production measured by ELISA in cultures containing 
soluble D4-mFc (15 and 5 μg/ml) or mouse IgG (15 and 5 μg/ml) control, 
CD4+ OTII T cells, antigen, and CD8+ DCs (fi  lled bars) or CD8− DCs (open 
bars) purifi  ed from LPS-injected C57BL/6 mice. (C and D) Naive CD4 T cells 
were isolated from AND TCR transgenic mice and cultured in vitro with 
I-Ek+ control (vector), Delta 4–expressing APCs (3 × 105/well; DCEK hi7) 
pulsed with 0.1 μg/ml mcc peptide (see Fig. S6). After 5 d, 105/well viable 
T cells were stimulated with plate-bound anti-CD3. Supernatants were 
taken after 48 h, and cytokine concentrations were determined by ELISA. 
The results are representative of two independent experiments. (E) Quan-
titative PCR for Delta 4 expression by splenic DC subsets purifi  ed from 
LPS-injected B10.BR mice and uninjected controls.JEM VOL. 204, July 9, 2007  1529
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IFN-γ production were measured 2 wk after antigen challenge. 
In agreement with the work of others, we found that LPS 
and OVA induced antigen-specifi  c T cell clonal expansion and 
IFN-γ production in wild-type mice, and that this was sub-
stantially decreased but not abolished in IL-12−/− recipients 
(Fig. 4 A; references 7 and 9). Injection of sD4-mFc reduced 
the IFN-γ production in IL-12−/− mice to nearly baseline 
levels (Fig. 4). We conclude that Delta 4 Notch-like ligand 
induces IL-12–independent Th1 diff  erentiation in vivo.
Our experiments show that IL-12 and Notch are redun-
dant and that IL-12 is responsible for up to 85–90% of the 
Th1 response, whereas the contribution by Notch is only 
10–15%. Therefore, blocking Notch in the presence of IL-12 
would not be expected to produce major changes in the Th1 
response. Furthermore, our data is consistent with the fi  nding 
that the intracellular domain of Notch binds directly to and 
activates the T-bet promoter, thereby potentiating Th1 re-
sponses (14–16, 22, 29). In BALB/c mice injected with anti-
CD40/Poly:IC, CD8+ DCs can also induce CD4+ T cells to 
produce IFN-γ by an additional IL-12–independent pathway 
involving CD70 (30).
We have shown that TLR4 ligation by LPS induces 
MyD88-dependent expression of Delta 4 Notch ligand spe-
cifi  cally on the CD8− DC subset, and that Delta 4 expression 
by these cells mediates Th1 development, accounting for 
IL-12–independent Th1 development in vivo. However, this 
alternative pathway to Th1 diff  erentiation appears to account 
for only 10–15% of the total Th1 response in wild-type mice. 
Nevertheless, several IFN-γ–dependent responses can proceed 
in the absence of IL-12 (4, 9–11). Furthermore, it is important 
to note that mice and humans defi  cient in IL-12 are very dif-
ferent from those that are IFN-γ defi  cient in that the former 
are only susceptible to a small number of pathogens (12, 13). 
Therefore, the existence of physiologically important IL-12–
independent pathways to stimulate IFN-γ is well documented. 
Our work identifi  es one such pathway and the cell that in-
duces it.
The two DC subsets in the mouse spleen (2, 31) share sev-
eral features, including a common precursor (32), but they dif-
fer in several important respects (2, 31). The two cell types 
show distinct global gene expression profi  les (33). CD8+ DCs 
have a unique capacity to take up dying cells in vivo and are 
enriched in components of the MHC I–processing pathway 
(34), whereas CD8− DCs are specialized to effi   cient antigen 
processing and presentation on MHC II (35). CD8+ DCs are 
found primarily in the T cell areas, whereas CD8− DCs reside 
in bridging channels, the marginal zone, and the red pulp, but 
they rapidly migrate into the T cell zone upon LPS administra-
tion or bacterial infection (5). Finally, CD8+ DCs appear to be 
more eff  ective in inducing Th1 T cell diff  erentiation (6, 7, 
25, 36). Nevertheless, we and others fi  nd that both CD8+ 
and CD8− DCs support Th1 diff  erentiation (9). After TLR 
  ligation, CD8+ DCs secrete IL-12, whereas the same signaling 
pathway leads to synthesis of Delta 4 in CD8− DCs. Why the 
two types of DCs evolved distinct mechanisms to stimulate 
Th1 diff  erentiation is not apparent but could be related to their 
specialization in antigen processing, anatomic location, or simply 
to an advantage in functional redundancy for regulating the 
Th balance in immune responses in vivo.
MATERIALS AND METHODS
Animals and procedures. C57BL6/J, C57BL6/SJL, IL-12p40−/−, 
IL12p35−/−, and OTII mice were purchased from The Jackson Laboratory. 
MyD88−/− mice were provided by S. Akira (Osaka University, Osaka, 
  Japan). Mice were used for experiments at the age of 6–8 wk. All mice were 
housed in specifi  c pathogen-free conditions and were treated in accordance 
with the institutional Animal Care and Use Committee protocols of The 
Rockefeller University.
T cell diff  erentiation experiments. CD4+ CD62Lhigh CD25low T cells 
were purifi  ed from the spleens of OTII mice using a CD4+ T cell isolation 
kit (Miltenyi Biotec), followed by single cell sorting using mAbs against 
CD62L, CD25, and CD4 (BD Biosciences). IFN-γ production was mea-
sured by ELISPOT or by intracellular cytokine staining (ICS). ELISPOT 
plates (MAHAS; Millipore) were coated with 10 μg of the anti–mouse 
IFN-γ mAb (clone R4-6A2; BD Biosciences) overnight at room tempera-
ture, and plates were blocked by incubation in PBS 1% BSA for 2 h at 
37°C. CD4+ T cells (2 × 105/well) were then cultured for 48 h at 37°C in 
the presence of 3 μM of OVA cognate peptide and CD11c+ DCs or 
CD11chigh CD8+ DEC+ or CD11chigh CD8− DEC− DCs (2 × 104/well). 
CD11c+ cells were purifi  ed using a CD11c+ isolation kit (Miltenyi Biotec) 
and where indicated preincubated for 6 h with 50 ng/ml LPS from Salmo-
nella abortus equi (Sigma-Aldrich). Splenic CD11chigh CD8+ DEC+ and 
CD11chigh CD8− DEC− DCs were purifi  ed from mice before or 12 h after 
injection with LPS (25 μg/mouse) by negative selection using CD19, 
Figure 4.  Delta 4 induces IL-12–independent Th1 differentiation 
in vivo. (A) Dot plots show the number of OTII T cells in the spleens of 
C57BL/6 SJL (WT) or IL-12−/− mice 2 wk after immunization with soluble 
OVA (2 mg/mouse) or OVA plus LPS (25 μg/mouse) in the presence or 
absence of sD4-mFc (100 μg/mouse). Numbers indicate percentages of 
CD45.1+ or CD45.2+ among CD4+ T cells. (B) Plots show numbers of 
IFN-γ–producing OTII cells (ICS). Numbers indicate percentages of CD45.1+ 
or CD45.2+ among CD4+ T cells.1530  DC SUBSETS, NOTCH, AND TH POLARIZATION | Skokos and Nussenzweig 
CD90, and DX5 beads (Miltenyi Biotec) and cell sorting on a FACSVan-
tage (BD Biosciences) using anti–DEC-biotin (Rockefeller University 
antibody facility) and streptavidin–Pe-Cy7, with anti–CD11c-PE and 
anti–CD8-FITC (BD Biosciences). The purity of DC subsets was >99%. 
For Western blot, the following antibodies were used: mouse monoclonal 
anti-Dll4, anti–α tubulin (R&D Systems and Abcam), anti–rat IgG2a–
horseradish peroxidase, and anti–rabbit–horseradish peroxidase (Southern-
Biotech and Jackson ImmunoResearch Laboratories). Cells were cultured 
in RPMI medium (10% FBS, penicillin, streptomycin, sodium pyruvate, 
and L-glutamine). Plates were developed with anti–IFN-γ, anti–IL-4, or 
anti–IL-10 biotinylated antibody (BD Biosciences), and spots were visual-
ized with avidin–horseradish peroxidase (Vector Laboratories), followed 
by DAB as substrate (Invitrogen). Spots were counted in an ELISPOT 
reader (Autoimmun Diagnostika GmbH).
ICS was performed on a 72-h co-culture of splenic CD11c+ and 
CD4+ T cells in the presence or absence of 3 μM OTII peptide. Brefeldin A 
(Sigma-Aldrich) was added in the co-culture for the last 4 h. Cells were 
harvested, stained for extracellular CD4 and Vα2, and then fi  xed and 
stained for IFN-γ or IL-4 (Intracellular Staining kit; BD Biosciences). 
IFN-γ, IL-4, IL-10, and IL-12 secretion was analyzed using ELISA Set, 
BD OptEIA (BD Biosciences). Concentrations were determined based on 
standard curves of recombinant IFN-γ, IL-4, IL-10, and IL-12 provided 
by the manufacturer.
2 μM CFSE (Invitrogen) -labeled CD4+ OTII T cells (106/well) were 
cultured for 60 h at 37°C with 5% CO2 in the presence of 3 μM of OVA 
cognate peptide and CD11chigh CD8+ DEC+ or CD11chigh CD8− DEC− 
DCs (105/well) purifi  ed as described previously. Cells were then stained 
with APC-conjugate anti-CD4 and PE-conjugate anti-CD69, and T cell 
proliferation and activation was followed by multicolor fl  ow  cytometry   
(FACSCalibur; Becton Dickinson).
RT-PCR. cDNA was generated from DNase1-treated (DNA free; Ambion) 
RNA (isolated using RNA-Bee; Tel-Test, Inc.). Fluorogenic probes were 
obtained from Biosearch Technologies. Quantitative PCR was performed 
for 40 cycles using an ABI (model 7900HT; Applied Biosystems). Samples 
were normalized for β-actin contents as described previously (14). Concen-
trations were determined on the basis of standard curves of plasmid DNA 
using software provided by the manufacturer.
Plasmid constructions. cDNA for mouse Delta 4 was provided by A. 
Duarte (Technical University of Lisbon, Lisbon, Portugal) and A. Freitas 
(Institut Pasteur, Paris, France). To generate soluble Delta 4, the cDNA was 
truncated at the codon CCC corresponding to proline (amino acid 517). 
cDNA for Fc (mIgG1) sequence was fused to the 3′ end coding region of 
mouse Delta 4 cDNA as described previously (37). Soluble D4-mFc was 
produced by transient transfection of 293T cells and was purifi  ed as de-
scribed previously (38).
Notch ligand binding assay. Delta-Serrate-Lag2 proteins are known to 
be ligands for Notch 1 and 2 receptors (37, 39). Binding of soluble Delta-
Serrate-Lag2 protein to the surface of pro–B cell line 32D was performed as 
described previously (37).
Delta 4 expression on APCs and in vitro T cell diff  erentiation. 
DCEK hi7 I-Ek–expressing fi  broblasts (provided by D. Amsen, University of 
Amsterdam, Amsterdam, Netherlands; reference 14) were transduced with 
a PMXpie retrovirus encoding an IRES GFP-linked mouse Delta 4 cDNA. 
I-Ek and CD80 levels were measured by staining with anti–I-Ek and anti-
CD80 antibodies (BD Biosciences; Fig. S6). 3 × 105 DCEK hi7 cells (treated 
for 1 h at 37°C with 50 μg/ml mitomycin C [Sigma-Aldrich]) were incu-
bated with naive AND CD4 T cells (2.5 × 105 /well; 24-well plates; Falcon) 
and the 81–103 moth cytochrome C peptide. Viable eff  ector cells were iso-
lated using Ficoll and restimulated at 105 cells per well (96-well plate; Falcon) 
with plate-bound anti-CD3. Cytokine concentration (48-h supernatants) 
was determined by ELISA (BD Biosciences).
Online supplemental material. Fig. S1 shows purity profi  les of naive 
CD4+ OTII T cells. Fig. S2 shows the role of LPS in the ability of splenic 
DC subsets to induce Th1 development. Fig. S3 shows the existence of an 
IL-12–independent Th1 diff  erentiation pathway in vitro. Fig. S4 shows pro-
duction of soluble Delta 4–mFc fusion protein. Fig. S5 shows the eff  ect of 
sDelta 4–mFc on T cell activation and proliferation. Fig. S6 shows expression 
level of Delta 4 in transfected fi  broblasts. The online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20062305/DC1.
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